Dr. John-Michael Sauer
And lastly this week, another non-profit organisation Critical Path Institute has announced Dr. John-Michael Sauer has joined the company as Executive Director of the Predictive Safety Testing Consortium (PSTC).
Dr. Sauer, who has led research teams at Pfizer-CovX in California and Covance in Arizona, has a background which “will greatly add to the consortium’s collaborative efforts among industry and regulatory scientists,” according to C-Path CEO Martha brumfield.